Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trialsJohn G.F. Cleland, Andrew J.S. Coats, Luís Manzano et al.|European Heart Journal|2017Cited by 643
Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart FailureDipak Kotecha, Andrew J.S. Coats, Simrat Gill et al.|Journal of the American College of Cardiology|2019Cited by 67
High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort studyEnric Monreal, José L. Casado, Elena Natera‐Villalba et al.|European Journal of Clinical Microbiology & Infectious Diseases|2020Cited by 59